Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

European Research Council grant · Running

TaRGet 2.0 Targeted single-capsule genomics applied to harmful cyanobacteria

Coordinator
Uppsala Universitet, Sweden
Runs
1 January 2027 to 30 June 2028
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101335155

What the project is doing

In the project's own words, from its summary on CORDIS.

Toxic algal blooms have major societal and economic impacts worldwide, and are becoming more frequent and severe due to climate warming. While many species cause harmful blooms, an understanding of the causes of toxicity and how to distinguish toxic from non-toxic cryptic strains is often lacking, hindering the development of preventive measures. In most cases, strain-resolved genomics is required to predict toxicity, but there exists no workflow that offers selective capture of target strains from environmental samples.

Here, we will develop, test, and deploy a highly innovative method called TaRGet 2.0, which combines short DNA tag capture inside semi permeable capsules with fluorescence-based cell sorting to isolate target cells at strain level, followed by amplicon depletion and genome amplification to generate uniform, high quality genomes. We will show the utility of TaRGet 2.0 using Microcystis as testbest, which is the most common and harmful of all bloom-forming cyanobacteria but for which genome availability is still very patchy.

The Proof of Concept will: (i) engineer and validate a single capsule workflow with strain specificity to Microcystis; (ii) demonstrate field ready monitoring by recovering hundreds of high-quality single-cell genomes from lake samples and building a strain genotype atlas; (iii) release standard operating procedures and a documented analysis pipeline; and (iv) assess adoption with monitoring stakeholders and a national genomics facility.

The expected outcomes are a robust, selective method to distinguish toxigenic from non toxigenic Microcystis at strain level, evidence of performance on real lake samples, and ready to use protocols that raise technology readiness for uptake. This will enable earlier, more precise risk assessment and targeted management by water utilities and agencies, reduce unnecessary interventions, and open a general route to targeted genome recovery of other priority microbes in One Health contexts.

Topics

Who is involved

OrganisationCityCountryRole
Uppsala UniversitetUppsalaSwedenCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI